Newsfeeds - Spark Newswire

2 minute read

How Is The Market Feeling About Checkpoint Therapeutics Inc?

Today, 6:15 AM

Checkpoint Therapeutics Inc's (NASDAQ:CKPT) short percent of float has risen 4.58% since last its last report. The company recently reported that it has 2.66 million shares sold short, which is 4.11% of all regular shares that are available for trading.

CKPT

1 minute read

HC Wainwright & Co. Maintains Buy on Checkpoint Therapeutics, Raises Price Target to $26

By Benzinga Newsdesk

Today, 6:15 AM

HC Wainwright & Co. analyst Joseph Pantginis maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and raises the price target from $17 to $26.

CKPT

3 minute read

Checkpoint Therapeutics Announces Topline Results From Registration-Enabling Trial Of Cosibelimab In Metastatic Cutaneous Squamous Cell Carcinoma; Study Met Primary Endpoint With 47.4% Objective Response Rate

By Bill Haddad

Today, 6:15 AM

Study met primary endpoint with 47.4% objective response rate Safety and tolerability profile consistent with previously reported data Planned BLA submission on track for later this year Conference call to

CKPT

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:15 AM

Gainers

AEVA

3 minute read

40 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 6:15 AM

Gainers

AHI

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 6:15 AM

ADTX

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 6:15 AM

Gainers

ADXS

1 minute read

Checkpoint Therapeutics Q2 EPS $(0.12) Down From $(0.09) YoY, Sales $155.00K Up From $42.00K YoY

By Benzinga Newsdesk

Today, 6:15 AM

Checkpoint Therapeutics (NASDAQ:CKPT) reported quarterly losses of $(0.12) per share. This is a 33.33 percent decrease over losses of $(0.09) per share from the same period last year. The company reported $155.00

CKPT

5 minute read

3 Penny Stocks To Buy According To Top Stock Market Analysts

By Pennystocks.com

Today, 6:15 AM

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Penny Stocks To Buy With Price Targets Up To 168% According To Analysts Maxim Group & H.C. Wainwright.

CKPT